Catalano M F, Lahoti S, Alcocer E, Geenen J E, Hogan W J
St. Luke's Medical Center, Pancreatic Biliary Center, Milwaukee, Wisconsin, USA.
Gastrointest Endosc. 1998 Dec;48(6):580-7. doi: 10.1016/s0016-5107(98)70039-2.
Obstructive disorders of the pancreas, including strictures, stones, sphincter of Oddi dysfunction, and pancreas divisum, are diagnostic and therapeutic challenges. Conventional extracorporeal ultrasound with secretin stimulation has been used as a noninvasive study to detect obstruction and predict outcome of therapy. Inconsistent results have been obtained because of the inherent limitations of standard ultrasonography. The aim of this study was to evaluate the behavior of the main pancreatic duct by endoscopic ultrasonography during secretin stimulation and to diagnose obstructive disorders of the pancreas.
Secretin-stimulated endoscopic ultrasound (SSEUS, 1 IU/kg secretin) was performed in 20 control subjects (no pancreatic or biliary disease), 40 patients with symptomatic chronic pancreatitis, 40 patients with symptomatic pancreas divisum, 20 patients with suspected sphincter of Oddi dysfunction, and 20 patients with suspected occlusion of pancreatic duct stents. Ductal diameter was measured by endoscopic ultrasonography at baseline and at 1-minute intervals, after administration of secretin, for 15 minutes. A result was determined to be abnormal when a 1 mm or greater dilation of the pancreatic duct was observed from baseline after secretin administration.
Of the 40 patients with symptomatic chronic pancreatitis, SSEUS correctly predicted obstructive pathology (stones, strictures) in 12 of 13 patients (92%). Of the 40 patients with symptomatic pancreas divisum, 22 underwent stent therapy (16 of 22 with resolution of symptoms). SSEUS accurately predicted response to stent therapy in 13 patients (81%). Seven of twenty patients with suspected sphincter of Oddi dysfunction had abnormal sphincter manometry. SSEUS accurately predicted sphincter dysfunction in only 4 of 7 patients (57%). Finally, 20 patients with suspected occlusion of pancreatic duct stents were studied. Of the 14 stent occlusions confirmed at ERCP, SSEUS correctly predicted premature occlusion in 12 patients (86%).
SSEUS appears to be a useful diagnostic modality in the evaluation of patients with suspected obstructive disorders of the pancreas and it can predict which patients may respond to endoscopic therapy.
胰腺阻塞性疾病,包括狭窄、结石、Oddi括约肌功能障碍和胰腺分裂症,在诊断和治疗方面都具有挑战性。传统的体外超声检查联合促胰液素刺激已被用作一种非侵入性检查,以检测梗阻情况并预测治疗结果。由于标准超声检查存在固有限制,所获结果并不一致。本研究的目的是通过内镜超声检查评估促胰液素刺激期间主胰管的表现,并诊断胰腺阻塞性疾病。
对20名对照受试者(无胰腺或胆道疾病)、40例有症状的慢性胰腺炎患者、40例有症状的胰腺分裂症患者、20例疑似Oddi括约肌功能障碍的患者以及20例疑似胰管支架闭塞的患者进行了促胰液素刺激内镜超声检查(SSEUS,1 IU/kg促胰液素)。在基线时以及注射促胰液素后,每隔1分钟通过内镜超声检查测量胰管直径,持续15分钟。当观察到注射促胰液素后胰管较基线扩张1mm或更大时,结果判定为异常。
在40例有症状的慢性胰腺炎患者中,SSEUS正确预测了13例患者中的12例(92%)的阻塞性病变(结石、狭窄)。在40例有症状的胰腺分裂症患者中,22例接受了支架治疗(22例中有16例症状缓解)。SSEUS准确预测了13例患者(81%)对支架治疗的反应。20例疑似Oddi括约肌功能障碍的患者中有7例括约肌测压异常。SSEUS仅准确预测了7例患者中的4例(57%)的括约肌功能障碍。最后,对20例疑似胰管支架闭塞的患者进行了研究。在ERCP证实的14例支架闭塞中,SSEUS正确预测了12例患者(86%)的过早闭塞。
SSEUS似乎是评估疑似胰腺阻塞性疾病患者的一种有用的诊断方法,并且它可以预测哪些患者可能对内镜治疗有反应。